Clinical Trial Update: Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a novel radiopaque embolic agent for prostatic artery embolisation in symptomatic benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• radiopaque embolic agent

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Benign Prostatic Hyperplasia | Phase 2 | Status: UNKNOWN